Article
Dysfunctional diversity of p53 proteins in adult acute myeloid leukemia: projections on diagnostic workup and therapy.
Blood - 10 Aug 2017
Prokocimer Miron, Molchadsky Alina, Rotter Varda
Abstract excerpt
The heterogeneous nature of acute myeloid leukemia (AML) and its poor prognosis necessitate therapeutic improvement. Current advances in AML research yield important insights regarding AML genetic, epigenetic, evolutional, and clinical diversity, all in which dysfunctional p53 plays a key role. As p53 is central to hematopoietic stem cell functions, its aberrations affect AML evolution, biology, and therapy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
